Related Experiment Video
Updated: Mar 6, 2026

Incorporating Target Protein Structure Flexibility and Dynamics in Computational Drug Discovery Using Ensemble-Based Docking Analysis
Published on: June 20, 2025
MLDTA an Ensemble-Driven Multimodal Model with Dynamic Fusion for Drug-Target Affinity Prediction
Xiaohan Mao1,2, Peng Zhang1,2, Xinyu Xu1,2
1State Key Laboratory on Technologies for Chinese Medicine, Pharmaceutical Process Control and Intelligent Manufacture (Jiangsu Kanion Pharmaceutical Co., Ltd. & Nanjing University of Chinese Medicine), Nanjing, 210000, China.
Abstract:
Existing drug-target binding affinity (DTA) models still face two major challenges. First, current multimodal approaches often rely on fixed fusion strategies or single model architectures, which limits their ability to adaptively capture the complex and heterogeneous relationships between drugs and targets. Second, heavy dependence on a single learning algorithm reduces model robustness and generalization, resulting in persistently large prediction errors. We propose MLDTA, a multimodal framework for DTA prediction that integrates dynamic feature fusion and ensemble-inspired modeling principles. MLDTA jointly exploits structural information, Geary autocorrelation descriptors, and tripeptide composition to construct complementary drug and target representations. Instead of relying on a single predictor, five representative DTA models from the literature are incorporated as auxiliary predictive modules (APMs), enabling affinity prediction from multiple algorithmic perspectives. These APMs are integrated with the learned drug and target representations through a dynamic fusion mechanism based on attention modules, which adaptively learns the relative importance of different features and predictive signals, thereby enhancing cross-modal interaction and reducing dependence on any individual model. Evaluation on standard datasets indicates that our model surpasses existing methods. Case studies further highlight MLDTA's effectiveness in drug screening.
Related Concept Videos
Pharmacodynamic Models: Additive and Proportional Drug Effect Model
Pharmacogenomics: Identification of New Drug Targets
Quantitative Aspects of Drug-Receptor Interaction
Drug Discovery: Overview
Targets for Drug Action: Overview
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
Pharmacodynamic Models: Overview

